CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Neuroscience Startups (947)
Mitobridge, formerly known as Mitokyne, is a biotechnology company focused on mitochondria-related drug discovery and development. The company is utilizing its screening platform to identify and develop novel drugs that improve mitochondria function ...Show all
Company (Acquired)
Phone: 617-401-9100
1030 Massachusetts Avenue
Suite 200
Cambridge, 02138
Massachusetts, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Mitobridge | $45M | Dec 1, 2017 |
| Vincere Biosciences | $1.3M | Apr 1, 2020 |
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Company | Status | Description | Investors |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Crystalline and salt forms of ppar agonist compounds | Oct 05, 2017 | Feb 23, 2021 | Patent |
| Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | Nov 13, 2019 | Feb 02, 2021 | Patent |
| Methods of treating acute kidney injury | Jul 27, 2017 | Dec 29, 2020 | Patent |
| Hmox1 inducers | Apr 08, 2020 | Sep 08, 2020 | Patent |
| Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases | Nov 02, 2016 | Apr 07, 2020 | Patent |
